Synergy Pharmaceuticals to Present at Roche Roche Colorado Corporation Peptide Symposium 2010

NEW YORK--(BUSINESS WIRE)--Synergy Pharmaceuticals, Inc. (OTCBB:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, announced today that Dr. Kunwar Shailubhai, the Company’s Chief Scientific Officer, will give an invited talk at the Roche Colorado Corporation Peptide Symposium 2010 to be held on September 14 – 16 at the St. Julien Hotel and Spa in Boulder, Colorado. Dr. Shailubhai’s talk entitled “Guanylate Cyclase-C Agonists as a New Class of Drug Candidates for GI Disorders and Inflammatory Bowel Disease” will be presented on September 15 in Session IA-Peptides in the Clinic.